Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181974 · ClinicalTrials.gov registry record · NA
Efficacy of a Fibrin Sealant in Burn Surgery
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00181974: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00181974 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181974, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of a fibrin glue in burn surgery with respect to hemostasis and skin graft fixation.
Interventions
- DRUG Tisseel Fibrin Sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2000-03 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181974
The ClinicalTrials.gov registry entry for NCT00181974 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tisseel Fibrin Sealant is the first listed.
NCT00181974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181974 about?
NCT00181974 is a clinical study titled "Efficacy of a Fibrin Sealant in Burn Surgery". The purpose of this study is to determine the effectiveness of a fibrin glue in burn surgery with respect to hemostasis and skin graft fixation.
What is the current status of trial NCT00181974?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2000-03. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00181974?
The interventions under investigation include: Tisseel Fibrin Sealant (DRUG).
Who is sponsoring clinical trial NCT00181974?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.